Evidence map›Paper›PMID 29397375›Full record

ArticleThe lancet. Diabetes & endocrinology2018

Once-weekly GLP-1R agonists: moving the goal posts.

Abd A Tahrani, Srikanth Bellary, Anthony H Barnett

Abstract readComment
PubMed Publisher
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Brain Amylin Signaling, Feeding, and Reward.Comprehensive Physiology · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Abd A TahraniInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK; Centre of Endocrinology Diabetes and Metabolism (CEDAM), Birmingham Health Partners, Birmingham, UK; Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK. Electronic address: a.a.tahrani@bham.ac.uk.
Srikanth BellaryDepartment of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK; School of Life & Health Sciences, Aston University, Birmingham, UK.
Anthony H BarnettInstitute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, UK; Department of Diabetes and Endocrinology, Heart of England NHS Foundation Trust, Birmingham, UK.

Funding

Department of Health CS-2013-13-029
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GoalsDiabetes MellitusGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHumansHypoglycemic AgentsLiraglutidePeptidesGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHypoglycemic AgentsLiraglutidePeptides

Identifiers

PMID29397375

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.